Media :: Rezolute, Inc. (RZLT)

Ensuring Patient-Friendly Clinical Trials For Complex Disorders — A Small Biopharma's Playbook

Head of Clinical Development, Dr. Brian Roberts - Congenital Hyperinsulinism Treatment Gaps and a Potential Solution

CEO Nevan Elam with Global Genes' Marie Daghlian - Rezolute Gains Rare Pediatric Disease Designation for RZ358 in Congenital Hyperinsulinism

How an Israeli web service, a bong-like insulin device and a Bay Area deal led this Peninsula biotech to attack a childhood disease

CEO Nevan Elam with Karen Jagoda - Developing Therapeutics for Rare Pediatric Diseases

Nature Biotechnology, and Nature Reviews Drug Discovery, November 2019 edition

CFO Keith Vendola speaks with Proactive's Christine Corrado at the 2019 BIO Investor Forum Conference

AntriaBio